ARX:ASX
Aroa Biosurgery Ltd
AU$ 0,50
arrow_downward
-1,96%(-0,0100) 1D
11 nov, 11:48:19 GMT+11 · AUD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor ARX genereren…
Openen
AU$ 0,51
Hoog
AU$ 0,51
Laag
AU$ 0,50
Beursw.
171,26 mln.
Gem. vol.
295,26K
Volume
28,46K
Koers/winst-verhouding
48,08
52 wk hoog
AU$ 0,78
52 wk laag
AU$ 0,46
WPA
AU$ 0,01
Uitstaande aandelen
345,90 mln.
Aantal medewerkers
261
Openen
AU$ 0,51
Hoog
AU$ 0,51
Laag
AU$ 0,50
Beursw.
171,26 mln.
Gem. vol.
295,26K
Volume
28,46K
Koers/winst-verhouding
48,08
52 wk hoog
AU$ 0,78
52 wk laag
AU$ 0,46
WPA
AU$ 0,01
Uitstaande aandelen
345,90 mln.
Aantal medewerkers
261
Nieuwsartikelen
Van webbronnen en nieuwspartners
investingLive
·
2 uur geleden
UBS keeps 8,900 S&P 500 target for end-2027, says 20% derating sets up strong gains
Investing.com
·
4 uur geleden
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.30%
The Motley Fool
·
3 uur geleden
Only 2 Novembers Since 1950 Have Started Worse for the S&P 500 Than This One. Here's What Followed the Other Weak Starts.
TOKENPOST
·
1 uur geleden
S&P 500 and Nasdaq Close Higher With Gains of 2.3% and 2.7%
Profiel
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
Over Aroa Biosurgery Ltd